Sep 23, 2022, 01:00 by User Not Found

Clinical Research News | Event adjudication is critical to clinical research for developing life-improving therapies. Implementing a well-managed adjudication program provides sponsors with peace of mind and an unbiased evaluation they may ultimately need to earn regulatory approval.

Sep 22, 2022, 09:35 by

Sep 22, 2022, 09:35 by

Sep 22, 2022, 09:35 by

Sep 22, 2022, 09:34 by

Elligo Health Research® today announced Chief Scientific Officer Rebecca Kush, Ph.D., will bring her expertise in clinical research, standards, and interoperability to her role as recently elected Chair of the Vulcan Advisory Council.

Sep 22, 2022, 09:34 by

WCG today announced the expansion of its Phase I review services, providing purpose-built operations for Phase I investigators.

Sep 22, 2022, 09:34 by

Dr. Vince Clinical Research (DVCR) today announced the launch of its new, world-class clinical pharmacology unit and headquarters in Overland Park, Kansas.

Sep 21, 2022, 09:54 by

Studies Will Examine Social Determinants of Health, Impact of Policy on Access, and Pandemic-Driven Disruptions to Healthcare Delivery

Sep 21, 2022, 09:54 by

QUINTEN HEALTH has announced that it has closed its financing round to advance disease modeling platforms and virtual twins in real-world.

Sep 21, 2022, 09:53 by

Dolomite Bio has announced the launch of Nadia Go — an affordable microfluidic system for custom microfluidic and genomics research.

Sep 21, 2022, 09:53 by

Temperature-controlled containers that combine robust, reliable, and reusable benefits for the pharmaceutical supply chain will be showcased on the Tower Cold Chain stand, 91H66, zone ICSE, at this year’s CPhI worldwide, in Frankfurt.

Sep 21, 2022, 09:52 by

Sep 21, 2022, 09:52 by

Sep 21, 2022, 09:52 by

Harley Street Medical Area has announced its Healthcare Conference is taking place on Wednesday 19th October 2022.

Sep 21, 2022, 09:51 by

Daman Digital (DAMAN), a digital healthcare partner based in Denmark, has announced its part in the ambitious European precision medicine healthcare project, SQUEEZE.

Sep 21, 2022, 09:51 by

Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ) (Olink) and is installing the largest commercial platform of the Olink® technology in the Americas outside of Olink itself to become a leading global certified service provider for the Olink Proximity Extension Assay (PEA) technology, a unique anti-body based proteomic technology.

Sep 21, 2022, 09:49 by

Curebase, a company committed to democratizing access to clinical studies, today announced it is partnering with Meru Health on a three-year clinical trial to determine the effectiveness of the online mental healthcare provider’s 12-week treatment program for reducing depression among primary care patients.

Sep 21, 2022, 01:00 by User Not Found

Clinical Research News | In July, the Pulmonary Fibrosis Foundation (PFF) launched the PFF Community Registry to begin collecting data directly from patients in the U.S. with pulmonary fibrosis (PF) and interstitial lung disease (ILD)—together with their nonprofessional caregivers and biological family members—as well as lung transplant recipients previously diagnosed with PF or ILD.

Sep 20, 2022, 10:11 by

VivoSTART GMP-grade leukopaks complement BioIVT’s GMP-grade human AB serum, providing a complete solution for advanced therapy development.

Sep 20, 2022, 10:11 by